Nalaganje...
Immunotherapy in pancreatic adenocarcinoma—overcoming barriers to response
Pancreatic adenocarcinoma (PAC) remains one of the leading causes of cancer-related death. Despite multiple advances in targeted and immune therapies, the 5-year survival in advanced PAC remains poor. In this review, we discuss some of the unique aspects of the tumor microenvironment (TME) in PAC th...
Shranjeno v:
| izdano v: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AME Publishing Company
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5848027/ https://ncbi.nlm.nih.gov/pubmed/29564181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.01.13 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|